CordLabs

Cord is a biotechnology company focused on developing a next-generation platform for the engineering and manufacturing of cell therapies. The company leverages advanced synthetic biology and computational tools to create highly precise, off-the-shelf cell products, primarily utilizing induced pluripotent stem cells (iPSCs). By streamlining the development process, Cord aims to overcome the current limitations of autologous therapies, such as high costs and manufacturing complexity. Their technology is designed to enable the rapid creation of scalable, effective treatments for a wide range of indications, including oncology and autoimmune disorders.